Wandercraft has acquired Ekso Bionics from a subsidiary of ChronoScale Holdings, merging their medical exoskeleton businesses to enhance rehabilitation and personal mobility solutions. This acquisition combines Wandercraft's robotics expertise with Ekso Bionics' established U.S. operations, expanding their market presence and support network.
The merger is significant as it integrates two leading players in the medical exoskeleton sector, with products like Atalante X and EksoNR already utilized in over 700 rehabilitation centers globally. Both companies hold FDA clearances and CE markings for various neurological and mobility conditions, ensuring a robust portfolio for healthcare providers and patients.
Looking ahead, Wandercraft aims to leverage this acquisition to broaden access to robotic mobility solutions, enhancing patient care and rehabilitation services. No further timeline was disclosed at the time of publication.
Editor's Note
The acquisition of Ekso Bionics by Wandercraft underscores a strategic move within the medical exoskeleton market, highlighting the growing importance of robotic solutions in rehabilitation. As healthcare providers increasingly adopt advanced technologies, this merger may enhance competitive dynamics and drive innovation in patient mobility solutions.
Copyright Notice
This briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? If you believe any material in this briefing infringes your copyright or other rights, please contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
Leave a comment